Strategies to Avoid Returning to Smoking
STARTS
Addressing Postpartum Mood and Weight Concerns to Sustain Smoking Cessation
2 other identifiers
interventional
300
1 country
1
Brief Summary
The purpose of this study is to evaluate the relative efficacy of a postpartum smoking relapse prevention program, Strategies to Avoid Returning to Smoking (STARTS), and a supportive, nondirective comparison condition (SUPPORT) to increase the proportion of women who remain abstinent through 12 months postpartum. We hypothesize that women randomized to STARTS will maintain higher rates of smoking abstinence at 6 and 12 months postpartum, and expect STARTS to increase the length of time abstinence is sustained relative to SUPPORT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 19, 2008
CompletedFirst Posted
Study publicly available on registry
September 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedMay 27, 2015
May 1, 2015
6.8 years
September 19, 2008
May 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abstinence at 12 months postpartum
through 12 months
Secondary Outcomes (1)
Explore factors associated with abstinence postpartum.
0-12 months
Study Arms (2)
SBT
ACTIVE COMPARATORWomen assigned to SBT (blue) will receive a six month program that offers to help them stay quit after having a baby.
CBT
EXPERIMENTALWomen assigned to CBT (pink) will receive a six month treatment designed to provide support and address the concerns of women who have just had a baby and do not want to resume smoking.
Interventions
Women will be assigned an individual counselor who will meet with them face-to-face six times and telephone them seven times. In these treatment sessions, the counselor will address postpartum mood and weight concerns.
Women will be assigned an individual counselor who will meet with them face-to-face six times and telephone them seven times. A non-specific, supportive condition will be delivered to women who want to remain smoke-free after they give birth.
Eligibility Criteria
You may qualify if:
- Women will be eligible to participate if they:
- report having smoked daily for at least one month during the 3 months prior to becoming pregnant;
- smoked at least 10 cigarettes per day before quitting;
- report no smoking in the four weeks prior to enrollment;
- are not currently smoking as verified by a CO less than 8ppm;
- are at least 'somewhat' motivated to remain abstinent postpartum and
- are at least 14 years of age.
You may not qualify if:
- Women with current, acute psychiatric disorders, including other substance use problems and symptoms that warrant immediate treatment will be referred for care and excluded from this trial.
- Women with psychiatric disorders (e.g., depressive or anxiety disorders), who are not acutely suicidal and in whom the symptoms are not severe enough to preclude participation in a randomized trial, will be eligible to participate. However, women taking psychiatric medications that may affect the mediators of treatment, such as antidepressant, anxiolytic or weight control medications, will be excluded from participation.
- Women who endorse current suicidality will be discussed immediately with the consulting physician and referred to the psychiatric emergency room for further evaluation as indicated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
UPMC
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (2)
Levine MD, Emery RL, Kolko Conlon RP, Marcus MD, Germeroth LJ, Salk RH, Cheng Y. Depressive Symptoms Assessed Near the End of Pregnancy Predict Differential Response to Postpartum Smoking Relapse Prevention Intervention. Ann Behav Med. 2020 Jan 24;54(2):119-124. doi: 10.1093/abm/kaz026.
PMID: 31219152DERIVEDLevine MD, Cheng Y, Marcus MD, Kalarchian MA, Emery RL. Preventing Postpartum Smoking Relapse: A Randomized Clinical Trial. JAMA Intern Med. 2016 Apr;176(4):443-52. doi: 10.1001/jamainternmed.2016.0248.
PMID: 26998789DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michele D Levine, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2008
First Posted
September 22, 2008
Study Start
September 1, 2007
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
May 27, 2015
Record last verified: 2015-05